Altreno Patient Benefits
Hydrating elements such as glycerin help moisturize the skin while tretinoin can boost collagen production. Together, the ingredients fight acne to improve overall skin texture.
Altreno® (tretinoin) Lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
Altreno is for topical use only. Not for ophthalmic, oral, or intravaginal use.
Skin Irritation: Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation.
Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation. Depending upon the severity of these adverse reactions, instruct patients to use a moisturizer, reduce the frequency of the application of Altreno, or discontinue use. Avoid application of Altreno to eczematous or sunburned skin.
Minimize unprotected exposure to ultraviolet light, including sunlight and sunlamps. Warn patients with frequent sun exposure and those with inherent sensitivity to sunlight to exercise caution. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.
Altreno contains soluble fish proteins. Use with caution in patients with known sensitivity or allergy to fish. Advise patients to contact their healthcare provider if they develop pruritus or urticaria.
The most common adverse reactions in clinical trials were application site dryness (4%), pain (3%), erythema (2%), irritation (1%) and exfoliation (1%).
It is not known whether topical administration of tretinoin could result in sufficient systemic absorption to produce detectable concentrations in human milk. The developmental health benefits of breastfeeding should be considered along with the mother’s clinical need for Altreno and any potential adverse effects on the breastfed child from Altreno.
To report suspected adverse reactions, contact Customer Service at 1-800-321-4576 or the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Altreno® (tretinoin) Lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
Altreno is for topical use only. Not for ophthalmic, oral, or intravaginal use.
Skin Irritation: Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation.
Free of fragrance, silicone, and alcohol
A lotion formulation, with low irritation
Easy to apply morning or evening
Fits easily into a routine, especially as it can be worn under makeup
Over 80% of users surveyed (n=30) said they found Altreno to be gentle on their skin. The barrier-supporting effects of the Altreno lotion vehicle are beneficial since a properly functioning barrier is essential to re-establishing healthy skin. Patients with different skin types will likely appreciate the hydrating effects of an easily applied topical lotion.
*Like all tretinoins, Altreno may cause dryness and irritation.
Altreno comes in 20g and 45g sizes for different patient needs.
Altreno 20g
Aged between 18-to-25.
Curious, and looking for a low commitment option.
The 20g size lasts up to 45 days, which can suit first-time users.
MSRP $60 per tube
Altreno® (tretinoin) Lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
Altreno is for topical use only. Not for ophthalmic, oral, or intravaginal use.
Skin Irritation: Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation.
Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation. Depending upon the severity of these adverse reactions, instruct patients to use a moisturizer, reduce the frequency of the application of Altreno, or discontinue use. Avoid application of Altreno to eczematous or sunburned skin.
Minimize unprotected exposure to ultraviolet light, including sunlight and sunlamps. Warn patients with frequent sun exposure and those with inherent sensitivity to sunlight to exercise caution. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.
Altreno contains soluble fish proteins. Use with caution in patients with known sensitivity or allergy to fish. Advise patients to contact their healthcare provider if they develop pruritus or urticaria.
The most common adverse reactions in clinical trials were application site dryness (4%), pain (3%), erythema (2%), irritation (1%) and exfoliation (1%).
It is not known whether topical administration of tretinoin could result in sufficient systemic absorption to produce detectable concentrations in human milk. The developmental health benefits of breastfeeding should be considered along with the mother’s clinical need for Altreno and any potential adverse effects on the breastfed child from Altreno.
To report suspected adverse reactions, contact Customer Service at 1-800-321-4576 or the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Altreno is a powerful Rx product, which means it requires a prescription. We can help you get in touch with a healthcare provider in two easy ways:
1. Online consultation
2. In-person visit